P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-04-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000829636.39178.19 |
| _version_ | 1797283133710663680 |
|---|---|
| author | E Terpos I Ntanasis-Stathopoulos E Kastritis E Hatjiharissi E Katodritou E Eleutherakis-Papaiakovou E Verrou M Gavriatopoulou A Leonidakis S Delimpasi P Malandrakis M-C Kyrtsonis M Papaioannou A Symeonidis MA Dimopoulos |
| author_facet | E Terpos I Ntanasis-Stathopoulos E Kastritis E Hatjiharissi E Katodritou E Eleutherakis-Papaiakovou E Verrou M Gavriatopoulou A Leonidakis S Delimpasi P Malandrakis M-C Kyrtsonis M Papaioannou A Symeonidis MA Dimopoulos |
| author_sort | E Terpos |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:26:12Z |
| format | Article |
| id | doaj.art-579405c6fc7d4586befc0fc650f6a975 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:26:12Z |
| publishDate | 2022-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-579405c6fc7d4586befc0fc650f6a9752024-03-02T19:07:48ZengWileyHemaSphere2572-92412022-04-016202010.1097/01.HS9.0000829636.39178.19202204002-00039P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDYE Terpos0I Ntanasis-Stathopoulos1E Kastritis2E Hatjiharissi3E Katodritou4E Eleutherakis-Papaiakovou5E Verrou6M Gavriatopoulou7A Leonidakis8S Delimpasi9P Malandrakis10M-C Kyrtsonis11M Papaioannou12A Symeonidis13MA Dimopoulos141 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece2 First Department of Internal Medicine, Aristotle University of Thessaloniki, School of Medicine, AHEPA University Hospital, Thessaloniki, Greece3 Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece3 Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece4 Health Data Specialists S.A., Athens, Greece5 Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece6 First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece2 First Department of Internal Medicine, Aristotle University of Thessaloniki, School of Medicine, AHEPA University Hospital, Thessaloniki, Greece7 Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greecehttp://journals.lww.com/10.1097/01.HS9.0000829636.39178.19 |
| spellingShingle | E Terpos I Ntanasis-Stathopoulos E Kastritis E Hatjiharissi E Katodritou E Eleutherakis-Papaiakovou E Verrou M Gavriatopoulou A Leonidakis S Delimpasi P Malandrakis M-C Kyrtsonis M Papaioannou A Symeonidis MA Dimopoulos P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY HemaSphere |
| title | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_full | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_fullStr | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_full_unstemmed | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_short | P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY |
| title_sort | p16 daratumumab monotherapy has a favorable effect on bone metabolism in patients with relapsed refractory multiple myeloma results of the phase 2 rebuild study |
| url | http://journals.lww.com/10.1097/01.HS9.0000829636.39178.19 |
| work_keys_str_mv | AT eterpos p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT intanasisstathopoulos p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT ekastritis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT ehatjiharissi p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT ekatodritou p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT eeleutherakispapaiakovou p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT everrou p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT mgavriatopoulou p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT aleonidakis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT sdelimpasi p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT pmalandrakis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT mckyrtsonis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT mpapaioannou p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT asymeonidis p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy AT madimopoulos p16daratumumabmonotherapyhasafavorableeffectonbonemetabolisminpatientswithrelapsedrefractorymultiplemyelomaresultsofthephase2rebuildstudy |